[go: up one dir, main page]

NO943645D0 - Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelser - Google Patents

Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelser

Info

Publication number
NO943645D0
NO943645D0 NO943645A NO943645A NO943645D0 NO 943645 D0 NO943645 D0 NO 943645D0 NO 943645 A NO943645 A NO 943645A NO 943645 A NO943645 A NO 943645A NO 943645 D0 NO943645 D0 NO 943645D0
Authority
NO
Norway
Prior art keywords
phenyl
treatment
neurodegenerative disorders
enantiomeric
ethylamine
Prior art date
Application number
NO943645A
Other languages
English (en)
Other versions
NO943645L (no
NO302170B1 (no
Inventor
Ronald Conrad Griffith
Robert John Murray
Michael Balestra
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929207339A external-priority patent/GB9207339D0/en
Priority claimed from GB929208290A external-priority patent/GB9208290D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of NO943645D0 publication Critical patent/NO943645D0/no
Publication of NO943645L publication Critical patent/NO943645L/no
Publication of NO302170B1 publication Critical patent/NO302170B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/10Antiepileptics; Anticonvulsants for petit-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/12Antiepileptics; Anticonvulsants for grand-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO943645A 1992-04-03 1994-09-30 Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav NO302170B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929207339A GB9207339D0 (en) 1992-04-03 1992-04-03 Pharmaceutical compound
GB929208290A GB9208290D0 (en) 1992-04-15 1992-04-15 Pharmaceutical compound having neuroprotective properties
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders

Publications (3)

Publication Number Publication Date
NO943645D0 true NO943645D0 (no) 1994-09-30
NO943645L NO943645L (no) 1994-11-16
NO302170B1 NO302170B1 (no) 1998-02-02

Family

ID=26300643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943645A NO302170B1 (no) 1992-04-03 1994-09-30 Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav

Country Status (29)

Country Link
EP (1) EP0633879B1 (no)
JP (2) JP3120810B2 (no)
KR (1) KR100259567B1 (no)
CN (1) CN1044367C (no)
AT (1) ATE163925T1 (no)
AU (2) AU3897693A (no)
CA (1) CA2133427C (no)
CZ (1) CZ288519B6 (no)
DE (1) DE69317411T2 (no)
DK (1) DK0633879T3 (no)
DZ (1) DZ1677A1 (no)
ES (1) ES2115055T3 (no)
FI (1) FI105025B (no)
HK (1) HK1009331A1 (no)
HU (1) HU211529A9 (no)
IL (1) IL105276A (no)
MA (1) MA22866A1 (no)
MX (1) MX9301935A (no)
MY (1) MY110149A (no)
NO (1) NO302170B1 (no)
NZ (1) NZ251384A (no)
PL (1) PL180014B1 (no)
RU (1) RU2128650C1 (no)
SG (1) SG47948A1 (no)
SK (1) SK281258B6 (no)
TW (1) TW282455B (no)
UA (1) UA29437C2 (no)
WO (1) WO1993020052A1 (no)
ZA (1) ZA932415B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
DE68925933T2 (de) * 1988-08-12 1996-08-14 Fisons Corp Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SE9901077D0 (sv) * 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901237D0 (sv) * 1999-04-06 1999-04-06 Astra Ab Novel use
SE9901340D0 (sv) 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
WO2007017652A2 (en) * 2005-08-10 2007-02-15 Astrazeneca Ab Arylakylamines for the treatment of cancer
JP5491524B2 (ja) * 2008-12-24 2014-05-14 アストラゼネカ・アクチエボラーグ エタンアミン化合物及びうつ病を処置するためのその使用
JP2015501652A (ja) 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag Gabr−a2診断
KR102469167B1 (ko) * 2013-11-05 2022-11-22 아스트라제네카 아베 Nmda 길항제 전구약물
CN115836052A (zh) * 2020-06-23 2023-03-21 拜尔哈文制药股份有限公司 (1s)-1-苯基-2-吡啶-2-基乙胺的局部制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925933T2 (de) * 1988-08-12 1996-08-14 Fisons Corp Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung

Also Published As

Publication number Publication date
ATE163925T1 (de) 1998-03-15
HK1009331A1 (en) 1999-05-28
NO943645L (no) 1994-11-16
CN1044367C (zh) 1999-07-28
NO302170B1 (no) 1998-02-02
FI105025B (fi) 2000-05-31
DE69317411T2 (de) 1998-07-30
SK281258B6 (sk) 2001-01-18
ZA932415B (en) 1993-10-22
RU2128650C1 (ru) 1999-04-10
DE69317411D1 (de) 1998-04-16
CZ240994A3 (en) 1995-12-13
AU7545696A (en) 1997-02-13
DK0633879T3 (da) 1998-09-28
SK117794A3 (en) 1995-05-10
MX9301935A (es) 1994-08-31
IL105276A (en) 1997-06-10
CZ288519B6 (cs) 2001-07-11
MA22866A1 (fr) 1993-12-31
FI944546A (fi) 1994-09-30
EP0633879B1 (en) 1998-03-11
EP0633879A1 (en) 1995-01-18
KR100259567B1 (ko) 2000-07-01
NZ251384A (en) 1996-10-28
SG47948A1 (en) 1998-04-17
RU94042465A (ru) 1996-07-20
PL180014B1 (pl) 2000-11-30
JPH07505385A (ja) 1995-06-15
TW282455B (no) 1996-08-01
JP2000319259A (ja) 2000-11-21
IL105276A0 (en) 1993-08-18
JP3120810B2 (ja) 2000-12-25
AU3897693A (en) 1993-11-08
UA29437C2 (uk) 2000-11-15
AU705419B2 (en) 1999-05-20
FI944546A0 (fi) 1994-09-30
CA2133427A1 (en) 1993-10-14
CA2133427C (en) 2003-06-10
CN1081669A (zh) 1994-02-09
DZ1677A1 (fr) 2002-02-17
WO1993020052A1 (en) 1993-10-14
HU211529A9 (en) 1995-11-28
MY110149A (en) 1998-02-28
ES2115055T3 (es) 1998-06-16

Similar Documents

Publication Publication Date Title
ITMI940326A0 (it) Derivati del 3,8-diazabiciclo[3.2.1.]lottano ad attivita' analgesica
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
AU6563596A (en) Treatment of tinnitis using neuroprotective agents
BR9609093A (pt) Uso de bis-1,2,4-triazóis para produção de um medicamento para tratamento de cãncer
NO943645L (no) Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin for behandling av neurodegenerative forstyrrelser
NO912797D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO972449D0 (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav
MA24130A1 (fr) PROCEDE DE PREPARATION D'ENANTIOMERES PURS D'ACIDES CYCLO-ALCANO-INDOLAZAINDOL ET PYRIMIDO-(1,2a) INDOL - CARBOCYCLIQUES ET LEURS DERIVES
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
NO924290L (no) Azabenzimidazoler for behandling av astma, artritt og lignende lidelser
ITMI931019A0 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
AU8715491A (en) Melatonin derivative having therapeutic activity in dermatology
AU6581294A (en) Ethanolamine derivatives useful for the treatment of gastrointestinal disorders
AU647608B2 (en) Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
IT1276321B1 (it) Derivati del carbossimetilidenecicloptimmidazolo procedimento di fabbricazione dei derivati e agenti terapeutici che contengono
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
AU8701298A (en) 2,3-dihydro-benzofuranol derivatives and process for resolving the same
IT1263076B (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
RU95111888A (ru) Способ лечения периферических поражений лицевого нерва
ITMI921770A1 (it) Composizioni farmaceutiche atte al trattamento dei disturbi della memoria.
ITMI931684A1 (it) Procedimento per la preparazione di derivati del 3, 4-diidrocarbostirile
ES1021588Y (es) Portarrollos perfeccionados.
ES1021895Y (es) Figura de centauro articulada, perfeccionada.
ES1019711Y (es) hito de arista perfeccionado.
NO953386D0 (no) Fremgangsmåte for fremstilling av N-metyl-2-(3-pyridyl)-(1R,2R)-2-tetrahydrotiopyrankarbotioamid-1-oksyd

Legal Events

Date Code Title Description
MK1K Patent expired